{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:02:49Z","timestamp":1790892169378,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,7]],"date-time":"2009-11-07T00:00:00Z","timestamp":1257552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s11307-009-0242-z","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T16:28:14Z","timestamp":1257524894000},"page":"2-8","source":"Crossref","is-referenced-by-count":14,"title":["High-Affinity \u03b1v\u03b23 Integrin Targeted Optical Probe as a New Imaging Biomarker for Early Atherosclerosis: Initial Studies in Watanabe Rabbits"],"prefix":"10.1007","volume":"12","author":[{"given":"Julie","family":"Heroux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Gharib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan S.","family":"Danthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Ohayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderic I.","family":"Pettigrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,7]]},"reference":[{"issue":"11","key":"242_CR1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","volume":"4","author":"AD Lopez","year":"1998","unstructured":"Lopez AD, Murray CC (1998) The global burden of disease, 1990\u20132020. Nat Med 4(11):1241\u20131243","journal-title":"Nat Med"},{"issue":"2","key":"242_CR2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R (1999) Atherosclerosis\u2013an inflammatory disease. N Engl J Med 340(2):115\u2013126","journal-title":"N Engl J Med"},{"issue":"6917","key":"242_CR3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874","journal-title":"Nature"},{"issue":"10","key":"242_CR4","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","volume":"25","author":"R Virmani","year":"2005","unstructured":"Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25(10):2054\u20132061","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"242_CR5","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1161\/01.CIR.0000093185.16083.95","volume":"108","author":"PM Winter","year":"2003","unstructured":"Winter PM, Morawski AM, Caruthers SD et al (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v) beta3-integrin-targeted nanoparticles. Circulation 108(18):2270\u20132274","journal-title":"Circulation"},{"issue":"1","key":"242_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1172\/JCI3756","volume":"103","author":"CM Storgard","year":"1999","unstructured":"Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA (1999) Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest 103(1):47\u201354","journal-title":"J Clin Invest"},{"issue":"5158","key":"242_CR7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","volume":"264","author":"PC Brooks","year":"1994","unstructured":"Brooks PC, Clark RA, Cheresh DA (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264(5158):569\u2013571","journal-title":"Science"},{"issue":"6","key":"242_CR8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.RES.77.6.1129","volume":"77","author":"M Hoshiga","year":"1995","unstructured":"Hoshiga M, Alpers CE, Smith LL, Giachelli CM, Schwartz SM (1995) Alpha-v beta-3 integrin expression in normal and atherosclerotic artery. Circ Res 77(6):1129\u20131135","journal-title":"Circ Res"},{"issue":"6","key":"242_CR9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.ATV.0000066686.46338.F1","volume":"23","author":"MJ Quinn","year":"2003","unstructured":"Quinn MJ, Byzova TV, Qin J, Topol EJ, Plow EF (2003) Integrin alphaIIbbeta3 and its antagonism. Arterioscler Thromb Vasc Biol 23(6):945\u2013952","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"242_CR10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1083\/jcb.142.2.595","volume":"142","author":"D Weerasinghe","year":"1998","unstructured":"Weerasinghe D, McHugh KP, Ross FP, Brown EJ, Gisler RH, Imhof BA (1998) A role for the alphavbeta3 integrin in the transmigration of monocytes. J Cell Biol 142(2):595\u2013607","journal-title":"J Cell Biol"},{"issue":"7","key":"242_CR11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","volume":"79","author":"PC Brooks","year":"1994","unstructured":"Brooks PC, Montgomery AM, Rosenfeld M et al (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7):1157\u20131164","journal-title":"Cell"},{"issue":"4","key":"242_CR12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.141.4.1083","volume":"141","author":"M Scatena","year":"1998","unstructured":"Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141(4):1083\u20131093","journal-title":"J Cell Biol"},{"issue":"1","key":"242_CR13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)63293-2","volume":"165","author":"AS Antonov","year":"2004","unstructured":"Antonov AS, Kolodgie FD, Munn DH, Gerrity RG (2004) Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis. Am J Pathol 165(1):247\u2013258","journal-title":"Am J Pathol"},{"issue":"2","key":"242_CR14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0021-9150(03)00097-2","volume":"170","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170(2):191\u2013203","journal-title":"Atherosclerosis"},{"issue":"21","key":"242_CR15","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2007.01.089","volume":"49","author":"B Doyle","year":"2007","unstructured":"Doyle B, Caplice N (2007) Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 49(21):2073\u20132080","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"242_CR16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","volume":"26","author":"PM Winter","year":"2006","unstructured":"Winter PM, Neubauer AM, Caruthers SD et al (2006) Endothelial alpha(v) beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 26(9):2103\u20132109","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"242_CR17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2967\/jnumed.108.052514","volume":"49","author":"J Waldeck","year":"2008","unstructured":"Waldeck J, Hager F, Holtke C et al (2008) Flucscorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an {alpha}v{beta}3 integrin-targeted fluorochrome. J Nucl Med 49:1845\u20131851","journal-title":"J Nucl Med"},{"issue":"14","key":"242_CR18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.CIR.103.14.1906","volume":"103","author":"GG Bishop","year":"2001","unstructured":"Bishop GG, McPherson JA, Sanders JM et al (2001) Selective alpha(v) beta(3)-receptor blockade reduces macrophage infiltration and restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation 103(14):1906\u20131911","journal-title":"Circulation"},{"issue":"11","key":"242_CR19","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/j.bmc.2005.03.024","volume":"13","author":"CA Burnett","year":"2005","unstructured":"Burnett CA, Xie J, Quijano J et al (2005) Synthesis, in vitro, and in vivo characterization of an integrin alpha(v) beta(3)-targeted molecular probe for optical imaging of tumor. Bioorg Med Chem 13(11):3763\u20133771","journal-title":"Bioorg Med Chem"},{"issue":"20","key":"242_CR20","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1021\/jm000133v","volume":"43","author":"ME Duggan","year":"2000","unstructured":"Duggan ME, Duong LT, Fisher JE et al (2000) Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist. J Med Chem 43(20):3736\u20133745","journal-title":"J Med Chem"},{"issue":"5","key":"242_CR21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/01.HYP.0000123070.31763.55","volume":"43","author":"DN Granger","year":"2004","unstructured":"Granger DN, Vowinkel T, Petnehazy T (2004) Modulation of the inflammatory response in cardiovascular disease. Hypertension 43(5):924\u2013931","journal-title":"Hypertension"},{"issue":"12A","key":"242_CR22","doi-asserted-by":"crossref","first-page":"3Q","DOI":"10.1016\/j.amjcard.2006.09.020","volume":"98","author":"P Libby","year":"2006","unstructured":"Libby P (2006) Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 98(12A):3Q\u20139Q","journal-title":"Am J Cardiol"},{"issue":"6","key":"242_CR23","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jacc.2005.03.074","volume":"46","author":"V Fuster","year":"2005","unstructured":"Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ (2005) Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 46(6):937\u2013954","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl K","key":"242_CR24","first-page":"94","volume":"14","author":"R Lassila","year":"1993","unstructured":"Lassila R (1993) Inflammation in atheroma: implications for plaque rupture and platelet-collagen interaction. Eur Heart J 14(Suppl K):94\u201397","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"242_CR25","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/0021-9150(95)90081-0","volume":"118","author":"AP Schroeder","year":"1995","unstructured":"Schroeder AP, Falk E (1995) Vulnerable and dangerous coronary plaques. Atherosclerosis 118(Suppl):S141\u2013S149","journal-title":"Atherosclerosis"},{"issue":"45","key":"242_CR26","doi-asserted-by":"crossref","first-page":"41832","DOI":"10.1074\/jbc.M105459200","volume":"276","author":"F Paulhe","year":"2001","unstructured":"Paulhe F, Racaud-Sultan C, Ragab A et al (2001) Differential regulation of phosphoinositide metabolism by alphaVbeta3 and alphaVbeta5 integrins upon smooth muscle cell migration. J Biol Chem 276(45):41832\u201341840","journal-title":"J Biol Chem"},{"issue":"5","key":"242_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/156652406778018635","volume":"6","author":"PR Moreno","year":"2006","unstructured":"Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V (2006) Neovascularization in human atherosclerosis. Curr Mol Med 6(5):457\u2013477","journal-title":"Curr Mol Med"},{"issue":"21","key":"242_CR28","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/01.CIR.0000017265.52501.37","volume":"105","author":"PR Moreno","year":"2002","unstructured":"Moreno PR, Purushothaman KR, Fuster V, O'Connor WN (2002) Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 105(21):2504\u20132511","journal-title":"Circulation"},{"issue":"4","key":"242_CR29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/hc0402.104119","volume":"105","author":"SH Wilson","year":"2002","unstructured":"Wilson SH, Herrmann J, Lerman LO et al (2002) Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 105(4):415\u2013418","journal-title":"Circulation"},{"issue":"5","key":"242_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2174\/156652406778018617","volume":"6","author":"M Sirol","year":"2006","unstructured":"Sirol M, Fuster V, Fayad ZA (2006) Plaque imaging and characterization using magnetic resonance imaging: towards molecular assessment. Curr Mol Med 6(5):541\u2013548","journal-title":"Curr Mol Med"},{"issue":"8","key":"242_CR31","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/1535-7163.MCT-06-0141","volume":"5","author":"R Sinha","year":"2006","unstructured":"Sinha R, Kim GJ, Nie S, Shin DM (2006) Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5(8):1909\u20131917","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"242_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/17435889.2.2.153","volume":"2","author":"JR McCarthy","year":"2007","unstructured":"McCarthy JR, Kelly KA, Sun EY, Weissleder R (2007) Targeted delivery of multifunctional magnetic nanoparticles. Nanomed 2(2):153\u2013167","journal-title":"Nanomed"},{"issue":"2","key":"242_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2310\/7290.2006.00009","volume":"5","author":"FA Jaffer","year":"2006","unstructured":"Jaffer FA, Nahrendorf M, Sosnovik D, Kelly KA, Aikawa E, Weissleder R (2006) Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials. Mol Imaging 5(2):85\u201392","journal-title":"Mol Imaging"},{"issue":"3","key":"242_CR34","first-page":"479","volume":"2","author":"J Xie","year":"2007","unstructured":"Xie J, Shen Z, Li KC, Danthi N (2007) Tumor angiogenic endothelial cell targeting by a novel integrin-targeted nanoparticle. Int J Nanomedicine 2(3):479\u2013485","journal-title":"Int J Nanomedicine"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-009-0242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-009-0242-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-009-0242-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T13:36:22Z","timestamp":1559396182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-009-0242-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,7]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s11307-009-0242-z","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,7]]}}}